Sunnybrook Research Institute ( Site 0105)

Toronto, Ontario M4N 3M5

1 studies enrolling now · 2 studies all time

What they study most

Breast Neoplasms, Squamous Cell Carcinoma

Studies at this site

• A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016) — Recruiting now
• Study of Pembrolizumab (MK-3475) in Adults With Recurrent/Metastatic Cutaneous Squamous Cell Carcinoma (cSCC) or Locally Advanced Unresectable cSCC (MK-3475-629/KEYNOTE-629) — Completed